Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 1
2013 1
2015 3
2016 2
2021 1
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial.
Zarrabi M, Shahrbaf MA, Nouri M, Shekari F, Hosseini SE, Hashemian SR, Aliannejad R, Jamaati H, Khavandgar N, Alemi H, Madani H, Nazari A, Amini A, Hassani SN, Abbasi F, Jarooghi N, Fallah N, Taghiyar L, Ganjibakhsh M, Hajizadeh-Saffar E, Vosough M, Baharvand H. Zarrabi M, et al. Stem Cell Res Ther. 2023 Jun 26;14(1):169. doi: 10.1186/s13287-023-03402-8. Stem Cell Res Ther. 2023. PMID: 37365605 Free PMC article. Clinical Trial.
Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial.
Attar A, Farjoud Kouhanjani M, Hessami K, Vosough M, Kojuri J, Ramzi M, Hosseini SA, Faghih M, Monabati A. Attar A, et al. Stem Cell Res Ther. 2023 Sep 23;14(1):264. doi: 10.1186/s13287-023-03495-1. Stem Cell Res Ther. 2023. PMID: 37740221 Free PMC article. Clinical Trial.
This study aimed to compare the effects of single versus double transplantation of Wharton's jelly MSCs (WJ-MSCs) on LVEF post-AMI. METHODS: We conducted a single-blind, randomized, multicenter trial. ...
This study aimed to compare the effects of single versus double transplantation of Wharton's jelly MSCs (WJ-MSCs) on LVEF post-AMI. M …
Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled study.
Nabavi SM, Karimi S, Arab L, Aghdami N, Joghtaei N, Maroufizadeh S, Jarooghi N, Bolurieh T, Abbasi F, Mardpour S, Azimyian V, Moeininia F, Sanjari L, Hosseini SE, Vosough M. Nabavi SM, et al. Mult Scler Relat Disord. 2023 Oct;78:104895. doi: 10.1016/j.msard.2023.104895. Epub 2023 Jul 17. Mult Scler Relat Disord. 2023. PMID: 37515913
The efficacy of transplantation of these cells should be evaluated through designing randomized clinical trials with larger sample sizes, different administration routes, other cell types (allogeneic adipose derived MSCs, allogeneic Wharton's jelly derived MSCs ), repeated …
The efficacy of transplantation of these cells should be evaluated through designing randomized clinical trials with larger sample sizes, di …
Platelet-Rich Plasma in Regenerative Medicine: Possible Applications in Management of Burns and Post-Burn Scars: A Review.
Hosseini MS, Nouri M, Zarrabi M, Fatemi MJ, Shpichka A, Timashev P, Hassan M, Vosough M. Hosseini MS, et al. Cell J. 2023 May 28;25(5):281-290. doi: 10.22074/cellj.2023.558213.1093. Cell J. 2023. PMID: 37300289 Free PMC article.
Burn injuries are devastating trauma with high rate of morbidities affecting several aspects of the patient's life. They require a long-time medical care and high costs. However, even following the best treatment procedures, post-burn scars are inevitable consequence of bu …
Burn injuries are devastating trauma with high rate of morbidities affecting several aspects of the patient's life. They require a lo …
Development of sandwich electrochemiluminescence immunosensor for COVID-19 diagnosis by SARS-CoV-2 spike protein detection based on Au@BSA-luminol nanocomposites.
Hosseini M, Sobhanie E, Salehnia F, Xu G, Rabbani H, Naghavi Sheikholeslami M, Firoozbakhtian A, Sadeghi N, Hossein Farajollah M, Reza Ganjali M, Vosough H. Hosseini M, et al. Bioelectrochemistry. 2022 Oct;147:108161. doi: 10.1016/j.bioelechem.2022.108161. Epub 2022 May 25. Bioelectrochemistry. 2022. PMID: 35659688 Free PMC article.
Coronavirus disease (COVID-19) is a new and highly contagious disease posing a threat to global public health and wreaking havoc around the world. It's caused by the Coronavirus that causes severe acute respiratory syndrome (SARS-CoV-2). ...
Coronavirus disease (COVID-19) is a new and highly contagious disease posing a threat to global public health and wreaking havoc around the …
Mesenchymal Stromal Cell Therapy Improves Refractory Perianal Fistula in Crohn's Disease: Case Series Clinical Interventional Study.
Vosough M, Nikfam S, Torabi SH, Sadri B, Ahmadi Amoli H, Basi A, Niknejadi M, Hossein-Khannazer N, Hosseini SE, Mardpour S, Azimian V, Jaroughi N, Aghdami N, Nikfam S, Amirzehni HR, Anushirvani A, Malekzadeh R, Baharvand H, Mohamadnejad M. Vosough M, et al. Cell J. 2022 Feb;24(2):62-68. doi: 10.22074/cellj.2022.7981. Cell J. 2022. PMID: 35279961 Free PMC article.
OBJECTIVE: Perianal fistulas in Crohn's disease (CD) are the main challenges in inflammatory bowel diseases (IBDs). ...No adverse events were observed during the six-month follow-up in these patients. Both the Crohn's Disease Activity Index (CDAI) and Perianal Disea …
OBJECTIVE: Perianal fistulas in Crohn's disease (CD) are the main challenges in inflammatory bowel diseases (IBDs). ...No adverse eve …
Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8).
Attar A, Monabati A, Montaseri M, Vosough M, Hosseini SA, Kojouri J, Abdi-Ardekani A, Izadpanah P, Azarpira N, Pouladfar G, Ramzi M. Attar A, et al. Trials. 2022 Aug 4;23(1):632. doi: 10.1186/s13063-022-06594-1. Trials. 2022. PMID: 35927674 Free PMC article.
METHODS: This single-blinded, randomized, multicenter trial aims to establish whether the intracoronary infusion of umbilical cord-derived Wharton's jelly MSCs (WJ-MSCs) helps prevent HF development after AMI. ...
METHODS: This single-blinded, randomized, multicenter trial aims to establish whether the intracoronary infusion of umbilical cord-derived W …
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR, Aliannejad R, Zarrabi M, Soleimani M, Vosough M, Hosseini SE, Hossieni H, Keshel SH, Naderpour Z, Hajizadeh-Saffar E, Shajareh E, Jamaati H, Soufi-Zomorrod M, Khavandgar N, Alemi H, Karimi A, Pak N, Rouzbahani NH, Nouri M, Sorouri M, Kashani L, Madani H, Aghdami N, Vasei M, Baharvand H. Hashemian SR, et al. Stem Cell Res Ther. 2021 Jan 29;12(1):91. doi: 10.1186/s13287-021-02165-4. Stem Cell Res Ther. 2021. PMID: 33514427 Free PMC article. Clinical Trial.
Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial.
Mohamadnejad M, Vosough M, Moossavi S, Nikfam S, Mardpour S, Akhlaghpoor S, Ashrafi M, Azimian V, Jarughi N, Hosseini SE, Moeininia F, Bagheri M, Sharafkhah M, Aghdami N, Malekzadeh R, Baharvand H. Mohamadnejad M, et al. Stem Cells Transl Med. 2016 Jan;5(1):87-94. doi: 10.5966/sctm.2015-0004. Epub 2015 Dec 10. Stem Cells Transl Med. 2016. PMID: 26659833 Free PMC article. Clinical Trial.
16 results